Intrinsic Value of S&P & Nasdaq Contact Us

scPharmaceuticals Inc. SCPH NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+129.3%

Stock Statistics — SCPH

scPharmaceuticals Inc. (SCPH) has a market capitalization of $302.2M and trades at $5.67. The 52-week range is 1.94-6.28.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3, Earnings Per Share (EPS) of $-1.91, annual revenue of $36.33M.

The stock has a beta of 0.30, operates in the Healthcare sector.

Trading Data
Current Price$5.67
52-Week Range1.94-6.28
Volume10.9M
Avg Volume (30D)1.45M
Market Cap$302.2M
Beta (1Y)0.30
Company
IPO Date2017-11-17
Employees162
CEOJohn H. Tucker
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS8106481059
CUSIP810648105
Income (Latest Year)
Revenue$36.33M
Gross Profit$24.97M
EBITDA$-77.43M
Operating Income$-64.78M
Net Income$-85.15M
EPS$-1.91
EPS Diluted$-1.91
Shares Outstanding$44.52M
Balance Sheet (Latest Year)
Total Assets$107.52M
Current Assets$105.85M
Cash & ST Investments$75.66M
Total Liabilities$94.2M
Total Debt$52.69M
Net Debt$-22.96M
Total Equity$13.32M
Debt / Equity3.96
Valuation Ratios
P/E Ratio-3
P/S Ratio8.32
P/B Ratio22.69
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message